• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pardes Biosciences, Inc. - Common Stock (NQ: PRDS )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 30, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 2.160 (5)
    Ask (Size) 2.210 (250)
    Prev. Close 2.160
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences
    From Foresite Capital
    Via Business Wire
    MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
    From MediPacific, Inc.
    Via Business Wire

    Performance

    More News

    Read More
    PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Why Pardes Biosciences Shares Are Rising Monday
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Recap: Pardes Biosciences Q1 Earnings
    Via Benzinga
    Pardes Biosciences Looks For Alternatives After Failed COVID-19 Study
    Via Benzinga
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    PRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Pardes Biosciences, Inc. (NASDAQ:PRDS) Investor Alert: Investigation over Potential Wrongdoing
    Via SBWire
    Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
    Via Benzinga
    Investigation Announced for Investors Who Lost Money with Shares of Pardes Biosciences, Inc. (NASDAQ: PRDS)
    Via SBWire
    Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
    Via Benzinga
    Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Vapotherm, Redwire And These 2 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.